191 related articles for article (PubMed ID: 20687121)
1. Pathological gambling in Parkinson disease is reduced by amantadine.
Thomas A; Bonanni L; Gambi F; Di Iorio A; Onofrj M
Ann Neurol; 2010 Sep; 68(3):400-4. PubMed ID: 20687121
[TBL] [Abstract][Full Text] [Related]
2. Is pathological gambling in Parkinson's disease reduced by amantadine?
Lee JY; Kim HJ; Jeon BS
Ann Neurol; 2011 Jan; 69(1):213-4; author reply 214-5. PubMed ID: 21280095
[No Abstract] [Full Text] [Related]
3. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.
Grant JE; Kim SW; Odlaug BL
Biol Psychiatry; 2007 Sep; 62(6):652-7. PubMed ID: 17445781
[TBL] [Abstract][Full Text] [Related]
4. Prospective prevalence of pathologic gambling and medication association in Parkinson disease.
Voon V; Hassan K; Zurowski M; Duff-Canning S; de Souza M; Fox S; Lang AE; Miyasaki J
Neurology; 2006 Jun; 66(11):1750-2. PubMed ID: 16769956
[TBL] [Abstract][Full Text] [Related]
5. [Monotherapy of Parkinson's disease with budipine. A double blind comparison with amantadine].
Malsch U; Bliesath H; Böther K; Ramm H; Lühmann R
Fortschr Neurol Psychiatr; 2001 Feb; 69(2):86-9. PubMed ID: 11253562
[TBL] [Abstract][Full Text] [Related]
6. Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.
Weintraub D; Sohr M; Potenza MN; Siderowf AD; Stacy M; Voon V; Whetteckey J; Wunderlich GR; Lang AE
Ann Neurol; 2010 Dec; 68(6):963-8. PubMed ID: 21154480
[TBL] [Abstract][Full Text] [Related]
7. Long-term antidyskinetic efficacy of amantadine in Parkinson's disease.
Wolf E; Seppi K; Katzenschlager R; Hochschorner G; Ransmayr G; Schwingenschuh P; Ott E; Kloiber I; Haubenberger D; Auff E; Poewe W
Mov Disord; 2010 Jul; 25(10):1357-63. PubMed ID: 20198649
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
Singh A; Kandimala G; Dewey RB; O'Suilleabhain P
J Clin Neurosci; 2007 Dec; 14(12):1178-81. PubMed ID: 17720504
[TBL] [Abstract][Full Text] [Related]
9. Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study.
Black DW; Arndt S; Coryell WH; Argo T; Forbush KT; Shaw MC; Perry P; Allen J
J Clin Psychopharmacol; 2007 Apr; 27(2):143-50. PubMed ID: 17414236
[TBL] [Abstract][Full Text] [Related]
10. Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease.
Santangelo G; Vitale C; Trojano L; Verde F; Grossi D; Barone P
Mov Disord; 2009 Apr; 24(6):899-905. PubMed ID: 19205072
[TBL] [Abstract][Full Text] [Related]
11. Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions.
Gerschlager W; Bloem BR
Mov Disord; 2009 Sep; 24(12):1858-60. PubMed ID: 19514056
[No Abstract] [Full Text] [Related]
12. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.
Voon V; Thomsen T; Miyasaki JM; de Souza M; Shafro A; Fox SH; Duff-Canning S; Lang AE; Zurowski M
Arch Neurol; 2007 Feb; 64(2):212-6. PubMed ID: 17296836
[TBL] [Abstract][Full Text] [Related]
13. Internet gambling and other pathological gambling in Parkinson's disease: a case series.
Wong SH; Cowen Z; Allen EA; Newman PK
Mov Disord; 2007 Mar; 22(4):591-3. PubMed ID: 17266073
[No Abstract] [Full Text] [Related]
14. Pathological gambling and obsessive compulsive disorder among methadone maintenance treatment patients.
Peles E; Schreiber S; Adelson M
J Addict Dis; 2009 Jul; 28(3):199-207. PubMed ID: 20155588
[TBL] [Abstract][Full Text] [Related]
15. Pathological gambling amongst Parkinson's disease and ALS patients in an online community (PatientsLikeMe.com).
Wicks P; MacPhee GJ
Mov Disord; 2009 May; 24(7):1085-8. PubMed ID: 19353722
[TBL] [Abstract][Full Text] [Related]
16. Amantadine reduces the duration of levodopa-induced dyskinesia: a randomized, double-blind, placebo-controlled study.
da Silva-Júnior FP; Braga-Neto P; Sueli Monte F; de Bruin VM
Parkinsonism Relat Disord; 2005 Nov; 11(7):449-52. PubMed ID: 16154788
[TBL] [Abstract][Full Text] [Related]
17. [Modification of Parkinson tremor by budipine. A comparative study with amantadine].
Iizuka J; Fischer R
Nervenarzt; 1986 Mar; 57(3):184-6. PubMed ID: 3515215
[No Abstract] [Full Text] [Related]
18. Pathological gambling caused by drugs used to treat Parkinson disease.
Dodd ML; Klos KJ; Bower JH; Geda YE; Josephs KA; Ahlskog JE
Arch Neurol; 2005 Sep; 62(9):1377-81. PubMed ID: 16009751
[TBL] [Abstract][Full Text] [Related]
19. [Amantadine for the treatment of levodopa dyskinesias in Parkinson's disease].
Cersósimo MG; Scorticati MC; Micheli FE
Medicina (B Aires); 2000; 60(3):321-5. PubMed ID: 11050808
[TBL] [Abstract][Full Text] [Related]
20. An open-label trial of escitalopram in the treatment of pathological gambling.
Black DW; Shaw M; Forbush KT; Allen J
Clin Neuropharmacol; 2007; 30(4):206-12. PubMed ID: 17762317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
